Actions of cytokines in relation to arachidonic acid metabolism and eicosanoid production

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 54, Issue 5, 1996, Pages 303-317

  Peplow, P V ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYTOKINE; ICOSANOID;

ANIMAL CELL; ANIMAL TISSUE; CELL INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030015590     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90044-7     Document Type: Review

References (147)

1. Hamblin A S, Cytokines and cytokine receptors. IRL Press, Oxford 1993; p. 1-19
2. Trotta P P, Cytokines: an overview. Am J Reprod Immunol 1991; 25: 137-141
3. Otari H, Siegel J P, Erdos M et al. Interleukin (IL)-2 and IL-3 induce distinct but overlapping responses in murine IL-3-dependent 32D cells transduced with human IL-2 receptor beta chain: involvement of tyrosine kinase(s) other than pS61 ck. Proc Natl Acad Sci USA 1992; 89: 2789-2793
4. Kanakura Y, Druker B, Cannistra S A et al. Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins. Blood 1990; 76: 706-715
5. Nakajima K, Wall R. Interleukin-6 signals activating jun B and tis 11 gene transcription in a B-cell hybridoma. Mol Cell Biol 1991; 11: 1409-1418
6. Taga T, Kishimoto T. Cytokine receptors and signal transduction. FASEB J 1993; 7: 3387-3396
7. Taga T, Hibi M, Hirata Y et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp 130. Cell 1989; 58: 573-581
8. Hibi M, Murakami M, Saito M et al. Molecular cloning and expression of an IL-6 signal transducer, gp 130. Cell 1990; 63: 1149-1157
9. Murakami M, Narazaki M, Hibi M et al. Critical cytoplasmic region of the IL-6 signal transducer, gp 130, is conserved in the cytokine receptor family. Proc Natl Acad Sci USA 1991; 88: 11349-11353
10. Roberts A B, Sporn M B. The transforming growth factor-betas. In: Peptide Growth Factors and Their Receptors (eds Sporn M and Roberts AB) Springer-Verlag, Heidelberg, Germany 1990, pp 421-472
11. Lin H Y, Wang X F, Ng-Eaton E, Weinberg R A, Lodish H F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992; 68: 775-785
12. Cantley L C, Auger K R, Carpenter C et al. Oncogenes and signal transduction. Cell 1991; 64: 281-302
13. Holms W E, Lee J, Kuang W J, Rice G C, Wood W I. Structure and functional expression of a human interleukin-8 receptor. Science 1991; 253: 1278-1280
14. Murphy P M, Tiffany H L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991; 253: 1280-1283
15. Spiegel A M. G proteins in cellular control. Curr Opin Cell Biol 1992; 4: 203-211
16. Oppenheim J J, Zachariae C O C, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991; 9: 617-648
17. Kupper R W, Dewald B, Jakobs K H, Bagiolini M, Gierschik P. G-protein activation by interleukin-8 and related cytokines in human neutrophil plasma membranes. Biochem J 1992; 282: 429-434
18. Fanslow W C, Clifford K, VandenBos T et al. A soluble form of the interleukin 4 receptor in biological fluids. Cytokine 1990; 2:398-401
19. Fanslow W C, Sims J E, Sassenfeld H et al. Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor. Science 1990; 248: 739-742
20. Hokin L E. Dynamic aspects of phospholipids during protein secretion. Int Rev Cytol 1968; 23: 187-208
21. Takai Y, Kikkawa U, Kaibuchi K, Nishizuka Y. Membrane phospholipid metabolism and signal transduction for protein phosphorylation. Adv Cyclic Nucleotide Protein Phosphorylation Res 1984; 18: 119-158
22. Graff G, Stephenson J H, Glass D B, Haddox M K, Goldberg N D. Activation of soluble splenic cell guanylate cyclase by prostaglandin endoperoxides and fatty acid hydroperoxides. J Biol Chem 1978; 253: 7662-7676
23. Hidaka H, Asano T. Stimulation of human platelet guanylate cyclase by unsaturated fatty acid peroxides. Proc Natl Acad Sci USA 1977; 74: 3657-3661
24. Coffey R G, Davis J S, Djeu J Y. Stimulation of guanylate cyclase activity and reduction of adenylate cyclase activity by granulocyte-macrophage colony-stimulating factor in human blood neutrophils. J Immunol 1988; 140: 2695-2701
25. + influx into human monocytes involves activation of a pertussis toxin-sensitive GTP-binding protein. J Biol Chem 1988; 263: 14093-14098
26. Lane T A, Lamkin G E, Wancewicz E. Modulation of endothelial cell expression of intercellular adhesion molecule 1 by protein kinase C activation. Biochem Biophys Res Commun 1989; 161: 945-952
27. Myers C L, Wertheimer S J, Schembri-King J, Parks T, Wallace R W. Induction of ICAM-1 by TNF-α, IL-1β, and LPS in human endothelial cells after downregulation of PKC. Am J Physiol 1992; 263: C767-C772
28. 1 cells. Kidney Int 1992; 42: 559-566
29. 1 cells. Am J Physiol 1991; 261: F945-F950
30. Pollard J K, Mitchell M D. Tumor necrosis factor alpha stimulates amnion prostaglandin biosynthesis primarily via an action on fatty acid cyclooxygenase. Prostaglandins 1993; 46: 499-510
31. Holladay C S, Wright R M, Spangelo B L. Arachidonic acid stimulates interleukin-6 release from rat peritoneal macrophages in vitro: evidence for a prostacyclin-dependent mechanism. Prostaglandins Leukotrienes Essential Fatty Acids 1993; 49: 915-922
32. 2 production in cultured bovine vascular endothelial cells. Arch Biochem Biophys 1992; 292: 600-604
33. Hannum C H, Wilcox C J, Arend W P et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343: 336-340
34. 4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264-265
35. Samuelsson B, Dahlen S E, Lindgren J A, Rouzer C A, Serhan C N. Leukotrienes and lipoxins: Structures, biosynthesis and biological effects. Science 1987; 237: 1171-1176
36. 4-induced activation signals and responses in neutrophils are short-lived compared to formylpeptide. J Immunol 1987; 138: 2626-2632
37. O'Flaherty J T, Nishihira J. Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils. J Immunol 1987; 138: 1889-1895
38. Smith R J, Sam L M, Justen J M, Leach K L, Epps D E. Human polymorphonuclear neutrophil activation with arachidonic acid. Br J Pharmacol 1987; 91: 641-649
39. 4 synthesis. J Immunol 1988; 140: 4315-4322
40. Di Persio J, Billing P, Kaufman S et al. Characterization of the human granulocyte-macrophage colony stimulating factor receptor. J Biol Chem 1988; 263: 1834-1841
41. Ulich T R, Busser K, Longmuir K J. Cytokine- and calcium ionophore A23187-mediated arachidonic acid metabolism in neutrophils. Cytokine 1990; 2: 280-286
42. Berkow R L, Dodson M R. Biochemical mechanisms involved in the priming of neutrophils by tumor necrosis factor. J Leuk Biol 1988; 44: 345-352
43. 2+ ionophore A23187. Clin Exp Immunol 1987; 70: 484-490
44. Schroder J M. The monocyte-derived neutrophil activating peptide (NAP/ interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J Exp Med 1989; 170: 847-863
45. Barton B E, Mayer R, Jackson J V, Clark M A. Two pathways of signal transduction are activated in the same cell by different cytokines. Immunopharmacol Immunotoxicol 1991; 13: 199-218
46. 2 by cytokines and its prevention by dexamethasone. Adv Exp Med Biol 1992; 318: 1-10
47. 2. J Biol Chem 1989; 264: 5768-5775
48. 2 and Its Regulatory Factors (Mukherjee A ed), Plenum Publishing Corp, New York 1990; p. 173-184
49. Chang J, Gilman S C, Lewis A J. Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL 1 action. J Immunol 1986; 136: 1283-1287
50. Suffys P, Van Roy F, Fiers W. Tumor necrosis factor and interleukin 1 activate phospholipase in rat chondrocytes. FEBS Lett 1988; 232: 24-28
51. Godfrey R W, Johnson W J, Hoffstein S T. Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism. Biochem Biophys Res Commun 1987; 142: 235-241
52. Leighton J D, Pfeilschifter J. Interleukin 1- and tumor necrosis factor-stimulation of prostaglandin E2 synthesis in MDCK cells, and potentiation of this effect by cycloheximide. FEBS Lett 1990; 259: 289-292
53. Lyons-Giordano B, Davis G L, Galbraith W, Pratta M, Arner E C. Interleukin-1 beta stimulates phospholipase A2 mRNA synthesis in rabbit articular chondrocytes. Biochem Biophys Res Commun 1989; 164: 488-495
54. 2 mRNA levels, and eicosanoid formation in rabbit chondrocytes. Biochem Biophys Res Commun 1989; 165: 1079-1084
55. 2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett 1990; 261: 171-174
56. 2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem 1990; 265: 12745-12748
57. 2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991; 266: 2647-2651
58. van den Bosch H. Intracellular phospholipases A. Biochim Biophys Acta 1980; 604: 191-246
59. 2: protection of membranes from lipid peroxidation damage. Trends Biochem Sci 1987; 12: 31-34
60. 2 by cytokines inhibiting bone formation and mineralization. Biochem Biophys Res Commun 1992; 188: 1047-1053
61. Needleman P, Turk J, Jakschik B A, Morrison A R, Lefkowith J B. Arachidonic acid metabolism. Ann Rev Biochem 1986; 55: 69-102
62. Raz A, Wyche A, Siegel N, Needleman P. Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J Biol Chem 1988; 263: 3022-3028
63. Coyne D W, Nickols M, Bertrand W, Morrison A R. Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids. Am J Physiol 1992; 263: F97-F102
64. 2 production in mesangial cells. Biochem Biophys Res Commun 1990; 173: 718-724
65. 2 biosynthesis in amnion cells. J Biol Chem 1988; 263: 7846-7854
66. Tashjian A H, Levine L. Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvaria. Biochem Biophys Res Commun 1978; 85: 966-975
67. Yoneda T, Pratt R M. Mesenchymal cells from the human embryonic palate are highly responsive to epidermal growth factor. Science 1981; 213: 563-565
68. Habenicht A J R, Goerig M, Grulich J et al. Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase. J Clin Invest 1985; 75: 1381-1387
69. Herrmann F, Lindemann A, Gauss J, Mertelsmann R. Cytokine-stimulation of prostaglandin synthesis from endogenous and exogenous arachidonic acids in polymorphonuclear leukocytes involving activation and new synthesis of cyclooxygenase. Eur J Immunol 1990; 20: 2513-2516
70. Pollard J K, Mitchell M D. Tumor necrosis factor alpha stimulates amnion prostaglandin biosynthesis primarily via an action on fatty acid cyclooxygenase. Prostaglandins 1993; 46: 499-510
71. Mitchell M D, Edwin S S, Lundin-Schiller S et al. Mechanism of interleukin-1β stimulation of human amnion prostaglandin biosynthesis: mediation via a novel inducible cyclooxygenase. Placenta 1993; 14: 615-625
72. Carlton D P, Jones D A, Whatley R E et al. Tumor necrosis factor increases cyclooxygenase activity in human umbilical vein endothelial cells. Clin Res 1992; 40: 193A
73. Jones D A, Carlton D P, McIntyre T M, Zimmerman G A, Prescott S M. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993; 268: 9049-9054
74. 2 from human dermal microvascular endothelial cells. Br J Dermatol 1990; 122: 153-164
75. Bull H A, Rustin M H A, Dowd P M. Release of prostacyclin from cultured human endothelial cells following prolonged exposure to histamine. Br J Dermatol 1989; 120: 757-766
76. Knudsen P J, Dinarello C A, Strom T B. Prostaglandins post-transcriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 1986; 137: 3189-3194
77. Rustin M H A, Bull H A, Dowd P M. Effect of human recombinant interleukin- 1α on release of prostacyclin from human endothelial cells. Br J Dermatol 1989; 120: 153-159
78. Weksler B B. Heparin and acidic fibroblast growth factor interact to decrease prostaglandin synthesis in human endothelial cells by affecting both prostaglandin H synthase and prostacyclin synthase. J Cell Physiol 1990; 142: 514-522
79. Rouzer C A, Shimizu T, Samuelsson B. On the nature of the 5-lipoxygenase reaction in human leukocytes: Characterization of a membrane-associated stimulatory factor. Proc Natl Acad Sci USA 1985; 82: 7505-7509
80. Dahinden C A, Zingg J, Maly F, de Week A L. Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals. J Exp Med 1988; 167: 1281-1295
81. Clancy R M, Dahinden C A, Hugli T E. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc Natl Acad Sci USA 1983; 80: 7200-7204
82. Silberstein D S, Owen W F, Gasson J C et al. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J Immunol 1986; 137: 3290-3294
83. Gagnon L, Filion L G, Dubois C, Rola-Pleszczynski M. Leukotrienes and macrophage activation: Augmented cytotoxic activity and enhanced interleukin 1, tumor necrosis factor and hydrogen peroxide production. Agents Actions 1989; 26: 141-147
84. Serhan C N, Hamberg M, Samuelsson B. Lipoxins: Novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci USA 1984; 81: 5335-5339
85. Soberman R J, Harper T W, Betteridge D, Lewis R A, Austen K F. Characterization and separation of the arachidonic acid 5-lipoxygenase and linoleic acid ω-6 lipoxygenase (arachidonic acid 15-lipoxygenase) of human polymorphonuclear leukocytes. J Biol Chem 1985; 260: 4508-4515
86. Hamberg M, Hamberg G. On the mechanism of the oxygenation of arachidonic acid by human platelet lipoxygenase. Biochem Biophys Res Commun 1980; 95: 1090-1097
87. Edenius C, Stenke L, Lindgren J A. On the mechanism of transcellular lipoxin formation in human platelets and granulocytes. Eur J Biochem 1991; 199: 401-409
88. Edenius C, Kumlin M, Bjork T, Anggard A, Lindgren J A. Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Lett 1990; 272: 25-28
89. Serhan C N, Hamberg M, Samuelsson B. Lipoxins A novel series of biologically active compounds. In: Prostaglandins, Leukotrienes and Lipoxins: Biochemistry, Mechanisms of Action and Clinical Applications (Bailey ed), Plenum, New York 1985: p. 3-16
90. Fiore S, Brezinski M E, Sheppard K A, Serhan C N. The lipoxin biosynthetic circuit and their actions with human neutrophils. Adv Exp Med Biol 1991; 314: 109-132
91. Brezinski M E, Gimbrone M A, Nicolaou K C, Serhan C N. Lipoxins stimulate prostacyclin generation by human endothelial cells. FEBS Lett 1989; 245: 167-172
92. Hansson A, Serhan C N, Haeggstrom J, Ingelman-Sundberg M, Samuelsson B. Activation of protein kinase C by lipoxin A and other eieosanoids. Intracellular action of oxygenation products of arachidonic acid. Biochem Biophys Res Commun 1986; 134: 1215-1222
93. Mandrup-Poulsen T, Bendtzen K, Nerup J et al. Affinity-purified human interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 1986; 29: 63-67
94. Zawalich W S, Diaz V A. Interleukin 1 inhibits insulin secretion from isolated perifused rat islets. Diabetes 1986; 35: 1119-1123
95. Mandrup-Poulsen T, Bendtzen K, Dinarello C A, Nerup J. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic β-cell cytotoxicity. J Immunol 1987; 139: 4077-4082
96. Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 1988; 37: 133-136
97. Campbell I L, Iscaro A, Harrison L C. IFN-γ and tumor necrosis factor-α. Cytotoxicity to murine islets of Langerhans. J Immunol 1988; 141: 2325-2329
98. Rabinovitch A, Baquerizo H, Sumoski W. Cytotoxic effects of cytokines on islet β-cells: evidence for involvement of eicosanoids. Endocrinol 1990; 126: 67-71
99. Duwe A K, Werkmeister J, Roder J C, Lauzon R, Payne U. Natural killer cell-mediated lysis involves an hydroxyl radical-dependent step. J Immunol 1985; 134: 2637-2644
100. Marshall P J, Lands W E M. In vitro formation of activators for prostaglandin synthesis by neutrophils and macrophages from humans and guinea pigs. J Lab Clin Med 1986; 108: 525-534
101. Rabinovitch A, Suarez W L, Thomas P D, Strynadka K, Simpson I. Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation. Diabetologia 1992; 35: 409-413
102. Slater T F. Free radical mechanisms in tissue injury. Biochem J 1984; 222: 1-15
103. Nathan C F, Tsunawaki S. Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effects on the oxidase. Ciba Found Symp 1986; 118: 211-230
104. Berton G, Zeni L, Cassatella M A, Rossi F. Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun 1986; 138: 1276-1282
105. Assayama K, Kooy N W, Burr I M. Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J Lab Clin Med 1986; 107: 459-464
106. Malaisse W J, Malaisse-Lagae F, Sener A, Pipeleers D G. Determinants of the selective toxicity of alloxan to the pancreatic β cell. Proc Natl Acad Sci USA 1982; 79: 927-930
107. Mathews N, Neale M L, Jackson S K, Stark J M. Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunol 1987; 62: 153-155
108. Berkow R L, Wang D, Larrick J W, Dodson R W, Howard T H. Enhancement of neutrophil Superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol 1987; 139: 3783-3791
109. English D, Broxmeyer H E, Gabig T G et al. Temporal adaptation of neutrophil oxidative responsiveness to n-formyl-methionyl-leucyl-phenylalanine. Acceleration by granulocyte-macrophage colony stimulating factor. J Immunol 1988; 141: 2400-2406
110. Marklund S L. Expression of extracellular Superoxide dismutase by human cell lines. Biochem J 1990; 266: 213-219
111. Marklund S L. Regulation by cytokines of extracellular Superoxide dismutase and other Superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 1992; 267: 6696-6701
112. Lefer A M, Tsao P, Aoki N, Palladino M A. Mediation of cardioprotection by transforming growth factor-β. Science 1990; 249: 61-64
113. Stuehr D J, Marietta M A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985; 82: 7738-7742
114. Ding A H, Nathan C F, Stuehr D J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141: 2407-2412
115. Broudy V C, Kaushansky K, Segal G M, Harlan J M, Adamson J W. Tumor necrosis factor type α stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci USA 1986; 83: 7467-7471
116. Munker R, Gasson J, Ogawa M, Koeffler H P. Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 1986; 323: 79-82
117. Nawroth P P, Bank I, Handley D et al. Tumor necrosis factor/ cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 1986; 163: 1363-1375
118. Dinarello C A. Interleukin-1. Rev Infect Dis 1984; 6: 51-95
119. Dinarello C A, Cannon J G, Mier J W et al. Multiple biological activities of human recombinant interleukin 1. J Clin Invest 1986; 77: 1734-1739
120. 2. J Clin Invest 1986; 77: 1857-1863
121. McIntyre T M, Zimmerman G A, Setoh K, Prescott S M. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest 1985; 76:271-280
122. 4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci USA 1986; 83: 2204-2206
123. Bussolino F, Camussi G, Baglioni C. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1α. J Biol Chem 1988; 263: 11856-11861
124. Wankowicz Z, Megyeri P, Issekutz A. Synergy between tumour necrosis factor α and interleukin-1 in the induction of polymorphonuclear leukocyte migration during inflammation. J Leukocyte Biol 1988; 43: 349-356
125. 2 synthesis by interleukin-1, tumor necrosis factor and products from activated human granulocytes. Prostaglandins Leukotrienes Essential Fatty Acids 1991; 44: 241-245
126. 2 production and the interleukin-1 specific binding on amnion cells. Prostaglandins Leukotrienes Essential Fatty Acids 1993; 49:923-928
127. 2 synthesis by amnion cells in culture: regulation by tumor necrosis factor-α, transforming growth factor β, and interleukin-1 receptor antagonist. Biochim Biophys Acta 1993; 1181: 31-36
128. 2 production in amnion-derived cells. Prostaglandins 1992; 44: 237-244
129. Ristimaki A, Ylikorkala O, Viinikka L. Effect of growth factors on human vascular endothelial cell prostacyclin production. Arteriosclerosis 1990; 10: 653-657
130. Tanner W G, Welborn M B, Shepherd V L. Tumor necrosis factor-α and interleukin-1α synergistically enhance phorbol myristate acetate-induced Superoxide production by rat bone marrow-derived macrophages. Am J Respir Cell Mol Biol 1992; 7: 379-384
131. Degliantoni G, Murphy M, Kobayashi M et al. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med 1985; 162: 1512-1530
132. Broxmeyer H E, Williams D E, Lu L et al. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-γ. J Immunol 1986; 136: 4487-4495
133. Rennick D, Yang G, Muller-Sieburg C et al. Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells. Proc Natl Acad Sci USA 1987; 84: 6889-6893
134. Santoli D, Yang Y C, Clark S C et al. Synergistic and antagonistic effects of recombinant human interleukin (IL)3, IL-1α, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines. J Immunol 1987; 139: 3348-3354
135. 2 production: implication for preterm labor. Am J Obstet Gynec 1992; 167: 222-226
136. Kunkel S L, Chensue S W, Phan S H. Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol 1986; 136: 186-192
137. Dinarello C A. Interleukin-1 and its biologically related cytokines. In: Lymphokines and the Immune Response ed S Cohen, CRC Press Inc, Boca Raton, Florida, 1990 p. 145-179
138. Haynes D R, Wright P F, Whitehouse M W, Vernon-Roberts B. The cyclo-oxygenase inhibitor, Piroxicam, enhances cytokine-induced lymphocyte proliferation in vitro and in vivo. Immunol Cell Biol 1990; 68: 225-230
139. Endres S, Ghorbani R, Kelley V E et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Eng J Med 1989; 320: 265-271
140. Kremer J M, Jubiz W, Michalek A et al. Fish-oil fatty acid supplementation in active rheumatoid arthritis. Ann Intern Med 1987; 106: 497-503
141. Rola-Pleszczynski M, Lemaire I. Leukotrienes augment interleukin 1 production by human monocytes. J Immunol 1985; 135: 3958-3961
142. Dinarello C A, Bishai I, Rosenwasser L J, Coceani F. The influence of lipoxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin-1). Int J Immunopharmacol 1984; 6: 43-50
143. Kunkel S L, Chensue S W. Arachidonic acid metabolites regulate interleukin-1 production. Biochem Biophys Res Commun 1985; 128: 892-897
144. Hajjar D P, Pomerantz K B. Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. FASEB J1992; 6: 2933-2941
145. Bittiner S B, Tucker W F, Cartwright I, Bleehan S S. A double-blind, randomised, placebo-controlled trial of fish oil in psoariasis. Lancet 1988; 1: 378-380
146. Brennan F M, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989; 2: 244-247
147. Feldmann M, Brennan F M, Chantry D et al. Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunol Rev 1991; 119: 105-123